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Abstract By using radioligand analysis, murine peritoneal macrophages were shown to express everal hundred high-affinity cell surface GMDP- 
biding sites (& 350 PM). PhotoaBinity labeling followed by SDS-PAGE enabled us to identify 32-34 and 38 kDa proteins inside these cells that 
bound GMDP specifically. 
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1. Introduction 
N-Acetylglucosaminyl-~l%N-acetyhnuramyl-alanyl-D-iso- 
glutamine (GMDP) is a fragment of bacterial cell wall de- 
monstrating a variety of biological activities [l]. It belongs to 
a large group of muramylpeptides (MPs) known to markedly 
affect the immune response. It’s adjuvant and anti-tumor ef- 
fects, and ability to induce resistance to bacterial and viral 
infections are well documented [1,2]. Despite of large number 
of studies the molecular mechanism of the MPs’ biological 
activity remains uncertain. Most likely their activity is mediated 
by receptor mechanisms. This hypothesis is supported by ster- 
eospecificity of action as well as by a saturating dose-response 
relationship [3,4]. 
MP-binding sites have been found on macrophages and 
other cells [5,6], but conllicting data were published regarding 
their location. Silverman et al. found a low number of mu- 
ramyldipeptide (MDP) receptors (several hundred per cell) on 
the surface of mm-me macrophages [6]. According to other 
investigators MP-binding sites are located inside macrophages 
and their numbers comprise dozens or hundreds of thousand 
per cell [5,7,8]. 
In this study we used 125-labeled derivatives of GMDP in 
order to characterize both external and internal GMDP-bind- 
ing sites of murine peritoneal macrophages. 
2. Materials and methods 
Female Balblc mice were purchased from the breeding house of 
Russian Medical Academy of Sciences (Stolbovaya, Moscow Region). 
GMDP and its derivatives were synthesized in the Laboratory of Pep- 
tide Chemistry, Shemvakin-Ovchinnikov Institute of Bioorganic Chem- 
istry, Russian -Academy of Sciences, as described in [9]- ‘251-labeled 
GMDP derivative, GMDP-Lys ([“‘I]Hp) (2000 Ci/mmol), synthesized 
as in [lO,ll], was a kind gift of A. Kaidalov (Engelgart Institute of 
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Molecular Biology, RAS, Moscow). Streptavidin-horseradish peroxi- 
dase conjugate was a kind gift of Dr. V. Kovalenko (Shemyakin- 
Gvchmnikov Institute of Bioorganic Chemistry, RAS). 
2.1. Synthesis of GMDP-Lys azidosalicilic acid, GMDP-Lys(AzS) 
The N-hvdroxvsuccinimide ester of 4-azidosalicilic acid W-IS-AxS) 
was synthebed k described in [12]. A dioxane solution of NI-IS-A& 
(250 pg in 25 ~1) was added to 800 pg of GMDP-Lys in 200 ~10.05 M 
phosphate buffer, pH 7.5. The reaction mixture was stirred for 30 min 
at room temperature in the dark. The conjugate was purified by reverse- 
phase HPLC using Nucleosil 7C, column (4 x 120 mm, Macherey- 
Nagel). The column was equilibrated with 10% aqueous acetonitrile, 
containing 0.05% triIluoroacetic acid (TFA). Fractions containing 
GMDP-Lys(AxS) were liophilii. The purity of the conjugate was 
proved by thin-layer chromatography on silica gel plates (Eastman- 
Kodak) using methanol/acetone, 1:10, as the mobile phase. Spots were 
visualized under a UV lamp. 
2.2. Radioiodination of GMDP-Lys(AzS) 
GMDP-Lys(AzS) (50 fig) in 50 ,ul of 0.05 M phosphate buffer, pH 
7.5, was placed in a vial along with 75 pg NaI, containing 0.09% of “‘1 
(1 mCi). Chloramine T (1% solution in deionized water, 10 ~1) was 
added. The reaction was stopped 30 s later by the addition of 10 ~1 1% 
aqueous olution of sodium thiosulphate. Iodinated conjugate was pu- 
r&d by HPLC on a Nucleosil7Cs column (Macherey-Nagel), equili- 
brated with 10% aqueous acetonitrile, containing 0.05% TFA. Elution 
was carried out with a 10-60% acetonitrile gradient in aqueous 0.05% 
TFA. Fractions (1 ml) were collected, and radioactivity measured using 
a Compugamma counter (LKB). Fractions containing GMDP- 
L~s([‘~I]AzS) were lyophilixed. The specific radioactivity of GMDP- 
L~s([‘~~I]AzS) was 3 x 10’ cpm/min/pmol. 
2.3. Isolation of mirine peritoneal macrophages 
Mice were killed by cervical dislocation. Peritoneal exudate cells were 
washed with Dulbecco’s PBS, supplemented with 5% fetal calf serum 
(FCS), and incubated for 1 h in plastic Petri dishes at 37°C in 5% COz. 
Non-adherent cells were washed out with Dulbecco’s PBS. Macro- 
phages were removed from the plastic surface with a cell scrapper. 
2.4. Analysis of kinetics of GMDP-L~s((“~I]H~) binding to viable 
macrophages 
GMDP-L~s([‘~I]H~) (2 x lo6 cpm, 0.45 mnol) in 10 ~1 PBS, was 
added to 5 x lo5 viable macronhaaes in 100 ul PBS. containing 1% BSA. 
The incubation was carried but for O-2 d at 4’C. AliquoG were re- 
moved from the incubation mixture every 2.5 min and filtered through 
Whatman GF/F filters which had been soaked for 12 h at 4°C in 25 
mM MOPS-KOH, 1 mM MgSO, buffer, pH 7.4 (buffer A), containing 
1% BSA, for reduction of non-specific binding. Each filter was washed 
three times with 3 ml of the same buffer and the radioactivity counted 
using Compugamma counter. 
00145793/94/%7.09 0 1994 Federation of European Biochemical Societies. All rights reserved. 
SSDZ 0014-5793(94)01219-9 
10 TN. Golovina et al. I FEBS Letters 356 (1994) 9-12 
For evaluation of non-specific binding, 140 nmol of unlabeled 
GMDP were added to macrophages along with GMDP-Lys([‘*‘I]Hp). 
Specific biding was calculated by subtracting non-specific binding 
from the total binding. The standard eviation was calculated as in [13]. 
3. Results and discussion 
In our earlier studies we failed to detect GMDP-binding sites 
on macrophage plasma membranes. Taking in account results 
obtained for muramyldipeptide (MDP) by Silverman et al. [6] 
this could be due to insufficient sensitivity of our method, 
namely flow cytometry. Using this method we could detect 
receptor molecules only if their number exceeded 1000 per cell. 
This value is higher than the number of MDP receptors found 
by Silverman. 
2.5. Dose-dependence of GMDP-L~s([‘~~IJH~) binding to viable 
macrophages 
Increasing amounts of labeled ligand (67.5 pmol-2.25 nmol) were 
added to 5 x 10’ viable cells in 100 ul PBS. containing 1% BSA. and 
0.01% sodium azide. Unlabeled GMi)P (lodo-fold excels) was included 
in control samples. Incubation was carried out for 30 min at 4°C. Cells 
were harvested onto Whatman GF/F filters, washed three times with 
buffer A containing 0.1% BSA, and the radioactivity counted using 
Compugamma counter. 
2.6. Inhibition analysis of GMDP-Lys([“‘I]Hp) binding to viable 
tnacrophages 
10 ~1 (2 x lo6 cpm, 0.45 nmol) GMDP-Lys([“‘IJHp) in PBS was 
added to 5 x lo5 macrophages in 100 ~1 PBS, containing 1% BSA, 
0.01% sodium azide. Increasing amounts (0.01-10 hmol) of inhibitor 
(GMDP, GMDP-Lys or L-GMDP) were added simultaneously with the 
radiolabeled ligand. The incubation was carried out for 30 min at 4°C. 
Cells were harvested onto GF/F filters and washed three times with 
buffer A containing 0.1% BSA. Radioactivity was counted using a 
Compugamma counter. 
2.7. Photoaffinity labeling of GMDP-binding molecules 
Macrophages (lo6 cells) were permeabilized with 0.001% digitonin in 
Dulbecco’s PBS for 1 min at 20°C and washed 3times with the same 
buffer. Cells were suspended in 1 ml Dulbecca PBS and incubated in 
da& Petri dishes with 3.3 run01 (10’ cnrnj of GMDP-Lvs(~‘~~I~A~S~ 
ior 30 min at 37°C in the dark. Peth disces &ere placed in-&i ref&irl 
ator for 5 min and irradiated for 10 min at a distance of 15 cm by a 
Black Ray CL-215 (UV Products Inc.). Control samples contained, 
along with GMDP-L~s([‘~‘I&S), unlabeled GMDP (lOOO-10,000 ex- 
cess) or GMDP-Lys(AzS) for evaluation of non-specific binding. 
2.8. Gel-electrophoresis 
SDS-PAGE was carried out in 12% slab gels according to Laemmli 
[14]. Cells were harvested and pelleted by centrifugation at400 x g for 
10 min at 4°C. The cell pellet was lysed with hot sample buffer and 
boiled for 5 min. After electrophoresis, gels were stained with Coomas- 
sie R-250, destained, ried and processed for autoradiography for5-15 
days at -70°C using RT-6M film. The autoradiographic films were 
scanned using a 2202 Ultroscan Laser Densitometer (LKB). 
In order to increase the sensitivity of the assay in this study 
we used radioligand analysis. It was performed with the aid of 
a ‘251-labeled erivative of GMDP-lysine, namely GMDP- 
Ly~([‘~‘1]Hp) (Fig. 1). Not long ago we showed that GMDP- 
Lys and its derivatives, substituted at the E-amino group of 
lysine, had biological activities identical to that of GMDP [15]. 
It enabled us to use these derivatives, in particular GMDP- 
Ly~([‘~‘flHp) and GMDP-L~s([‘~~I]A~S), in receptor-labeling 
studies. 
Plasma membrane GMDP-binding sites were detected by 
incubating viable macrophages with GMDP-L~s([‘~~I]H~) on 
ice, in the presence of sodium azide in order to prevent 
endocytosis. To differentiate specific and non-specific binding, 
inhibition analysis was carried out. Unlabeled GMDP (lOOO- 
fold excess) was used as an inhibitor. The difference between 
binding in the absence and the presence of unlabeled GMDP 
was considered as specific binding. 
A kinetic study of GMDP-L~s([“~I]H~) binding to murine 
peritoneal macrophages has shown that total binding increased 
upon an increase in incubation time, whereas specific binding 
remained almost unchanged already after 5 min incubation 
(data not shown). It should be noted that the level of non- 
specific binding was high. A similar high level of non-specific 
binding of radiolabeled MDP to cells was observed by Silver- 
man et al. [6]. 
Specificity of binding was confirmed by dose-dependent inhi- 
bition by GMDP and GMDP-Lys (Fig. 2). A GMDP analog 
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Fig. 1. Radiolabeled derivatives of GMDP. 
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Fig. 2. Inhibition analysis of GMDP-Lys([‘*‘I]Hp) binding to viable 
macrophages. Inhibition with GMDP (o), GMDP-Lys (0), L-GMDP 
0. 
with the L-configuration of the isoglutamine residue (L- 
GMDP) was a much less effective inhibitor, demonstrating a 
correlation with the absence of appreciable biological activity. 
Scatchard analysis of binding revealed (Fig. 3) that there 
were nearly 1000 plasma membrane GMDP-binding sites per 
cell with a dissociation constant of 350 pM. It should be noted 
that the Kd value coincided with that determined by Silverman 
et al. for MDP [6], where as the B,, was almost two-times 
higher [17]. 
The role of plasma membrane MP-binding sites remains un- 
certain. The data obtained by several groups indicated that to 
produce a biological effect, MPs have to be internalized by 
macrophages [7,16]. An intracellular MDP-binding protein 
with a molecular weight of 4@45 kDa was identified by Tenu 
et al. in rabbit alveolar macrophages [8]. Two types of GMDP- 
binding sites, with Kd’s of 20 and 540 nM, were reported by 
Sumaroka et al. to exist inside murine peritoneal macrophages 
PI. 
To further characterize these binding sites, namely to identify 
I 
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Fig. 3. Scatchard plot of binding of GMDP-L~s([‘~I]H~) to viable 
macrophages. 
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Fig. 4. Reverse-phase HPLC of GMDP-Lys(AzS). 
GMDP-binding proteins, we used the affinity labeling tech- 
nique. To covalently link GMDP to receptor proteins, a pho- 
toactivated erivative was synthesized. The 4azidosalicilic acid 
residue (AzS) was coupled to GMDP-Lys by use of succinimide 
ester [lo]. The conjugate GMDP-Lys(AzS) (Fig. 1) was purified 
by reverse-phase HPLC (Fig. 4): the dashed peaks on the chro- 
matogram, eluted at 2628% acetonitrile, represent wo GMDP 
anomers known to be always present in aqueous solutions [l 11. 
These two fractions were combined and subjected to radioiodi- 
nation by the chloramine T procedure [lo]. Purification of 
radiolabeled GMDP-L~s([*“~I]A~S) was achieved by reverse- 
phase HPLC. 
Digitonin-permeabilized macrophages were incubated with 
radiolabeled ligand at 37°C in order to facilitate GMDP- 
L~s([‘*~I]A~S) uptake by cells. Specificity of binding was evalu- 
ated by introducing lOOO-10,000 fold excess of unlabeled 
GMDP along with GMDP-L~s([‘~~I$~~S). Only around 40% of 
label was shown to bind specifically, indicating a high level of 
non-specific binding, obviously due to the iodoazidosalicilic 
acid residue. Nonetheless, GMDP competed with GMDP- 
L~s([‘~~I]A~S) for internal binding sites, enabling us to use the 
above-mentioned erivative for photoaffinity labeling of mac- 
rophages. 
After treating peritoneal macrophages with digitonin, perme- 
abilized cells were incubated with GMDP-L~s([‘*~I]A~S) in the 
absence or presence of unlabeled GMDP, washed several times 
with PBS and irradiated with UV. Cells were lysed with hot 
sample buffer and subjected to SDS-PAGE. After drying the 
gel, radiolabeled proteins were visualized by autoradiography. 
Affinity labeling demonstrated the presence of several 
GMDP-binding proteins (Fig. 5). Binding of radioligand to 
32-34 and 38 kDa proteins could be completely inhibited by 
unlabeled GMDP, indicating specificity, whereas binding to the 
43 kDa protein could be inhibited only partially. Complete 
inhibition of binding to the 43 kDa protein was achieved by 
using a 100 fold excess of non-iodinated GMDP-Lys(AzS) con- 
jugate. Thus, most likely, various parts of the GMDP-Lys(AzS) 
molecule contribute to its binding to the 43 kDa protein. In 
contrast to our finding, Tenu et al. reported that binding of a 
[‘251]AzS derivative of MDP to an internal 4045 kDa receptor 
of rabbit alveolar macrophages could be completely inhibited 
optical 
density 
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1 
gel length 
Fig. 5. Scan from the autoradiography film from SDS-PAGE of 
GMDP-Lys([‘2’I]AzS)-labeled p rmeabilized peritoneal macrophages. 
by MDP [8]. At the moment we can not answer the question 
of whether the 43 kDa MP-binding protein in murine macro- 
phages and the 40-45 kDa protein in rabbit macrophages per- 
form identical functions. 
An attempt o use the same approach to affinity label plasma 
membrane GMDP-binding proteins failed, evidently due to the 
low number or receptors and low yield of the coupling reaction 
(less than 5%). 
Thus, the most probable intracellular targets of GMDP in 
murine macrophages are the 32-34 and 38 kDa proteins. The 
same proteins were labeled when myelomonocytic WEHI- 
cells were studied (data not shown). Sequencing of these pro- 
teins is under way. 
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